Psycheceutical Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Psycheceutical General Information
Description
Operator of a biotech firm intended to enhance the safety and efficacy of therapeutic agents for the management of neuropsychiatric and pain conditions. The company's delivery system allows immediate and sustained drug delivery, with safe dosage control and consistent results, while avoiding the gastrointestinal tract and toxicity-related side effects by applying a topical compound at the back of the neck near the hairline, which penetrates peripheral nerve endings along the spinal cord to provide a direct path to neural tissue in the brain, enabling healthcare professionals to deliver psychedelic medicines safely and effectively.
Contact Information
Website
www.psycheceutical.com(Operating Subsidiary)
Corporate Office
- 515 East Las Olas Boulevard
- Suite 120
- Fort Lauderdale, FL 33301
- United States
Corporate Office
- 515 East Las Olas Boulevard
- Suite 120
- Fort Lauderdale, FL 33301
- United States
Psycheceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 3. Early Stage VC | 01-Jul-2023 | Completed | Clinical Trials - Phase 1 | |||
| 2. Merger/Acquisition | 19-Jan-2022 | $405K | Completed | Stealth | ||
| 1. Seed Round | 12-Oct-2021 | $405K | $405K | Completed | Stealth |
Psycheceutical Patents
Psycheceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024159167-A1 | Ketamine formulations suitable for topical delivery and related methods | Inactive | 26-Jan-2023 |
Psycheceutical Signals
Psycheceutical Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cantheon Capital | PE/Buyout | Minority |
Psycheceutical FAQs
-
When was Psycheceutical founded?
Psycheceutical was founded in 2020.
-
Where is Psycheceutical headquartered?
Psycheceutical is headquartered in Fort Lauderdale, FL.
-
What is the size of Psycheceutical?
Psycheceutical has 4 total employees.
-
What industry is Psycheceutical in?
Psycheceutical’s primary industry is Drug Discovery.
-
Is Psycheceutical a private or public company?
Psycheceutical is a Private company.
-
What is Psycheceutical’s current revenue?
The current revenue for Psycheceutical is .
-
How much funding has Psycheceutical raised over time?
Psycheceutical has raised $1.3M.
-
Who are Psycheceutical’s investors?
Cantheon Capital has invested in Psycheceutical.
-
Who acquired Psycheceutical?
Psycheceutical was acquired by Psycheceutical Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process